Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance

Novartis AGTrade
Charles Schwab Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Charles Schwab Corporation Common Stock — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Charles Schwab Corporation Common Stock trades at $107.87 (market cap $186.25B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.

NVSSCHW
Market Cap
$295.37B$186.25B
Sector
HealthFinancials
52-Week High
$168.62$108.02
52-Week Low
$119.31$85.35
Enterprise Value
$336.69B
Dividend Yield
3.07%1.19%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Charles Schwab Corporation Common Stock

Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.

Read more on SCHW